Prof. JAGADISH SINGH
Professor
Work Experience
11 Years
Area of Specialization
Synthetic Medicinal Chemistry and Phytochemistry. Evaluation of Anticancer, Antidiabetic, Antimicrobial activities.
Projects & Patents
2013 Funding Agency: UGC “Synthesis, Characterization and Antiproliferative activity of Oxadiazole Derivatives”. Work as: Principal Investigator Amount: Rs.06 Lakhs, Duration: 02 years 2018 Funding Agency: DST-SERB "Design, Synthesis, Characterization and Evaluation of Anticancer Activity of Some new 1,3, 4-oxadiazoles derivatives clubbed with Isoindoline 1,3-dione" Work as: Principal Investigator Amount: 3284000Lakhs Duration:03 years
Education
M. Pharm., Ph. D.
Achievments/Awards/Honors
Publications
List of BEST publications: 1. Matore BW, Roy PP, Singh J. Discovery of novel VEGFR2-TK inhibitors by phthalimide pharmacophore based virtual screening, molecular docking, MD simulation and DFT. Journal Of Biomolecular Structure and Dynamics. (2023) [I F: 5.2] 2. Bajaj S, Roy PP, Singh J. Synthesis, thymidine phosphorylase inhibitory and computational study of novel 1,3,4-oxadiazole-2-thione derivatives as potential anticancer agents. Computational Biology and Chemistry. (2018)151-160. [I F: 2.87] 1. Bajaj S, Roy PP, Singh J. 1, 3, 4-Oxadiazoles as telomerase inhibitor: Potential anticancer agents.Anti-Cancer Agents in Medicinal Chemistry, (2017)17, 1869-1883. [IF-2.50] 2. P Banjare, J Singh, P P Roy.Acute Rat and Mouse Oral Toxicity Determination of anticholinesterase inhibitor carbamate pesticides: A QSTR Approach. Molecular Informatics. (2019)38,8-9. [IF-2.50] 3. P Banjare, J Singh, P P Roy. Design and combinatorial library generation of 1H 1,4 benzodiazepine 2,5 diones as photosystem-II inhibitors: A public QSAR approach / Beni-Suef Univ. J. Basic Appl. Sci. (2017) 6,219–231. 4. P P Roy, S Bajaj, T K Maity, J Singh. Synthesis and Evaluation of Anticancer Activity of 1, 3, 4-Oxadiazole Derivatives against Ehrlich Ascites Carcinoma Bearing Mice and Their Correlation with Histopathology of Liver. Indian Journal of Pharmaceutical Education and Research, (2017) 51(2),260-269[IF-0.42] 5. A KGupta, R Raushan, J Singh and P P Roy. Exploring the QSAR Analysis of imidazole-4, 5- and pyrazine-2,3-Dicarboxamides Derivatives Using Online Available Resources. Letters in Drug Design & Discovery (2016), 13, 1-8. [IF-1.15] 6. S Bajaj, V Asati, J Singh, P P Roy. “1, 3, 4-Oxadiazoles: An emerging scaffold to target growth factors, enzymes and kinases as anticancer agents”. European Journal of Medicinal Chemistry (2015)97, 124-141, [IF-6.51] 7. T Ghosh, J Singh & T K Maity. Evaluation of antitumor activity of stigmasterol, a constituent isolated from Bacopa monnieri Linn aerial parts against Ehrlich Ascites Carcinoma in mice, Orient Pharm Exp Med 11: 41–49 (2011) DOI 10.1007/s13596-011-0001-y. 8. T Ghosh, T K Maity& J Singh, Antihyperglycemic Activity of Bacosine, a Triterpene from Bacopa monnieri, in Alloxan-Induced Diabetic Rats, Planta Med (2011);77: 804–808[I F: 2.75]. 9. J Singh, A. K. Balaraman, R Rajapandi, A Mondal, B C Maiti& T K Maity, Synthesis, Anticancer activity of some 1, 3, 4-oxadiazole derivatives against Ehlrich Ascites Carcinoma bearing mice model, Pharmacologyonline. (2010) 1: 406-416. 10. S Dash, A K Balaraman, J Singh, M Kundu, B C Maiti& T K Maity, Synthesis of some 3, 5-disubstituted 1, 3, 4 -Oxadiazole Derivatives and Anticancer Activity on EAC animal model, Med Chem Resea. (2010) DOI 10.1007/s00044-010-9455-6. [IF-1.95].